Better Therapeutics, Inc. (BTTX) Financials
BTTX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 10.7 million | 20.7 million |
2023-06-30 | 11.6 million | 22.4 million |
2023-03-31 | 12.8 million | 22.6 million |
2022-12-31 | 22.9 million | 23.8 million |
BTTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -5.9 million | 427000 |
2023-06-30 | -5.6 million | 478000 |
2023-03-31 | -9.2 million | 410000 |
2022-12-31 | -6.7 million | 449000 |
BTTX Net Income
No data available :(
BTTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 6.6 million | - | - |
2023-06-30 | 6.2 million | - | - |
2023-03-31 | 6.1 million | - | - |
2022-12-31 | 15.7 million | - | - |
BTTX Shares Outstanding
BTTX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 5000 | 1.8 million | 2.1 million | 1.4 million |
2023-06-30 | 503000 | 2.2 million | 3.1 million | 1.7 million |
2023-03-31 | 521000 | 3.4 million | 3.4 million | 2.1 million |
2022-12-31 | 360000 | 3.0 million | 3.6 million | 1.7 million |
BTTX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 841000 |
2023-06-30 | - | 797000 |
2023-03-31 | - | 755000 |
2022-12-31 | - | 721000 |
BTTX
Price: $0.01
52 week price:
Earnings Per Share: -1.10 USD
P/E Ratio: -0.14
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 41300
Market Capitalization: 545156